首页> 美国卫生研究院文献>Frontiers in Oncology >Moderately Escalated Hypofractionated (Chemo) Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer
【2h】

Moderately Escalated Hypofractionated (Chemo) Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer

机译:螺旋强度调节技术治疗中度逐步升级的超分割(化学)放射治疗在III期不可切除的非小细胞肺癌中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Purpose: To assess clinical outcomes and toxicities in patients with stage III unresectable non-small cell lung cancer (NSCLC) treated with a moderately escalated hypofractionated radiotherapy delivered with Helical Intensity-Modulated Technique in combination with sequential or concurrent chemotherapy.>Materials and Methods: Sixty-one consecutive patients considered non-progressive after two cycles of induction chemotherapy were treated with a moderately escalated hypofractionated radiation course of 30 daily fractions of 2.25–2.28 Gy each administered in 6 weeks up to a total dose of 67.5–68.4 Gy (range, 64.5–71.3 Gy). Thirty-two received sequential RT after two more cycles (total = 4 cycles) of chemotherapy, while 29 were treated with concurrent chemo-radiation. The target was considered the gross tumor volume and the clinically proven nodal regions, without elective nodal irradiation.>Results: With a median follow up of 27 months (range 6–40), 1-year and 2-year OS rate for all patients was 77 and 53%, respectively, with a median survival duration of 18.6 months in the sequential group and 24.1 months in the concomitant group. No Grade ≥4 acute and late toxicity was reported. Acute Grade 3 treatment-related pneumonitis was detected in 10% of patients. Two patients, both receiving the concurrent schedule, developed a Grade 3 acute esophagitis. The overall incidence of late Grade 3 lung toxicity was 5%. No patients experienced a Grade 3 late esophageal toxicity.>Conclusion: A moderately hypofractionated radiation course delivered with a Helical Intensity-Modulated Technique is a feasible treatment option for patients with unresectable locally advanced NSCLC receiving chemotherapy (sequentially or concurrently). Hypofractionated radiotherapy with a dedicated technique allows safely dose escalation, minimizing the effect of tumor repopulation that may occur with prolonged treatment time.
机译:>目的:评估采用螺旋强度调制技术联合序贯或并发的中度逐步扩大分割放疗所治疗的III期不可切除的非小细胞肺癌(NSCLC)患者的临床结局和毒性>材料和方法:在连续两个诱导化疗后被认为是非进行性疾病的连续患者中,有61名患者接受了中等程度的次分割放射疗程,每天30次,每次2.25–2.28 Gy,共6次总剂量为67.5–68.4 Gy(范围为64.5–71.3 Gy)。在另外两个化疗周期(总共= 4个周期)后,有32个接受了连续放疗,而同时进行化学放疗则治疗了29个。目标被认为是总肿瘤体积和临床证实的淋巴结区域,无选择性淋巴结照射。>结果:中位随访时间为27个月(6-40岁),1年和2所有患者的年OS率分别为77%和53%,序贯组中位生存期为18.6个月,伴随组中位生存期为24.1个月。没有报道≥4级的急性和晚期毒性。在10%的患者中发现了急性3级治疗相关的肺炎。两名同时接受治疗的患者发生了3级急性食管炎。晚期3级肺毒性的总发生率为5%。没有患者会发生3级晚期食道毒性。 )。采用专用技术的超分割放射疗法可以安全地逐步增加剂量,从而最大程度地减少了因延长治疗时间而可能引起的肿瘤重聚的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号